Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on September 8, 2025

Pasithea Therapeutics Announces Enrollment of Cohort 2 following Positive Safety Review Committee (SRC) Recommendation for its Ongoing Phase 1/1b Clinical Trial of PAS-004 in Adult NF1 Patients
-- Recommendation that trial escalate to next dose level of 8mg tablet -- -- Initial interim clinical data from first two cohorts expected in Q1 2026 -- MIAMI, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the …

Picard Medical, Inc. Announces Presentation at H.C. Wainwright Global Investment Conference
TUCSON, Ariz., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that Patrick NJ Schnegelsberg, Chief Executive Officer, will present in-person at the H.C. Wainwright 27th Annual …

Wix Announces Proposed Private Offering of $750 million of 0.00% Convertible Senior Notes due 2030
NEW YORK, September 8, 2025 – Wix.com Ltd. (Nasdaq: WIX) (“Wix”), the leading SaaS website builder platform1, today announced its intention to offer, subject to market conditions and other factors, $750 million aggregate principal amount of 0.00% …

Attralus Presents New Data on Its Pan-Amyloid Diagnostic Imaging Candidates at ASNC 2025
124I-evuzamitide, the first pan-amyloid diagnostic imaging agent, demonstrated 100% sensitivity and specificity for the diagnosis of cardiac amyloidosis in patients suspected of or diagnosed with cardiac amyloidosis in ATTR, AL, and other rare types of …

Vertex to Present at Goldman Sachs Communacopia + Technology Conference
KING OF PRUSSIA, Pa., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ:VERX), a global provider of tax technology solutions, today announced that David DeStefano, Chief Executive Officer, and John Schwab, Chief Financial Officer, will participate in …

IMDX Enrolls First Patient in GraftAssureDx Clinical Trial and Welcomes New Hospital Participants
iMDx’s ClinicalTrials.gov listing now names 10 leading transplant centers, up from 5 previously GraftAssureDx remains on track for FDA submission by end of 2025, commercial launch in 2026 NASHVILLE, Tenn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Insight …

Tonix Pharmaceuticals Presents Clinical Data on Tonmya™ for the Treatment of Fibromyalgia at PAINWEEK 2025
Tonmya was approved by FDA on August 15, 2025 for the treatment of fibromyalgia and is the first new FDA approved treatment for fibromyalgia in over 15 years Two pivotal Phase 3 studies demonstrated Tonmya significantly reduced fibromyalgia pain compared …

Dianthus Therapeutics Announces Positive Data for Claseprubart (DNTH103) from the Phase 2 MaGic Trial in Generalized Myasthenia Gravis, Supporting Its Potential Best-In-Class Profile
Claseprubart 300mg and 600mg Q2W doses both achieved statistically significant and clinically meaningful improvements in Myasthenia Gravis Activities of Daily Living (MG-ADL) and Quantitative Myasthenia Gravis (QMG) scores at Week 13 Claseprubart …

SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent
Significant Development in the Estimated $30 Billion Global Infection-Prevention Market SALT LAKE CITY, Utah, Sept. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), today announced that the United States …

Ocular Therapeutix™ to Host Investor Day on September 30, 2025
Company to highlight ongoing AXPAXLI™ wet AMD registrational program, strategy and next steps in NPDR and DME, and global commercial opportunity for AXPAXLI Event to feature global retinal disease experts Dr. Arshad M. Khanani MD, MA, FASRS; Professor …

Centric Software positioned as a Leader and Ace Performer in the 2025 SPARK Matrix™: Product Lifecycle Management (PLM) for Process Industries by QKS Group
Pune, India, Sept. 08, 2025 (GLOBE NEWSWIRE) -- The QKS Group SPARK Matrix™ provides competitive analysis …

Innovid by Mediaocean Recognized as the Most Valuable Pioneer in QKS Group’s AI Maturity Matrix™: AdTech, 2025
Pune, India, Sept. 08, 2025 (GLOBE NEWSWIRE) -- QKS Group, a global research and advisory firm, has announced the release of its latest report, “Leveraging AI in AdTech to Revolutionize Ad Performance and Deliver Personalized Customer Engagement.” The …

TPE : la trésorerie tombe à son plus bas niveau de l’année
Axonaut dévoile les résultats de son Observatoire de la trésorerie des TPE et PME françaises pour le deuxième trimestre 2025. Les chiffres confirment un contexte économique dégradé pour les petites entreprises. Au deuxième trimestre 2025, la trésorerie se …

Customs Assured Realizes 30% Productivity Gain by Streamlining Customs Declarations with Descartes and AiDock
LONDON and ATLANTA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that U.K.-based customs consultancy Customs Assured is streamlining …

Esker et PwC Poland s’associent pour accélérer la transformation digitale de la fonction finance
LYON, France — 8 septembre 2025 — Esker, pionnière des solutions d’Agentic AI dédiées à l’Office of the CFO, annonce aujourd’hui une collaboration avec l’équipe Finance Transformation de PwC Poland. L’objectif : proposer aux clients en Pologne, dans la …

Dataprana Signs $10 Million Deal with Bitmain for New Immersion Units
MIAMI, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Dataprana, Inc. (“Dataprana”) has signed a $10 million agreement with Bitmain Technologies Delaware Ltd. (“Bitmain”) for the purchase of over 3,000 Antminer S21 Immersion units, which will be hosted at its mining …

Regeneron Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antibody-Blockers of Cat and Birch Allergies
In separate cat and birch allergen-challenge trials, single doses of allergen-specific antibody blockers significantly reduced allergy symptoms compared to placebo Data from these trials will support further Phase 3 development TARRYTOWN, N.Y., Sept. 08, …

Liberty Gold Announces Strategic 9.9% Investment by Centerra Gold Inc.
VANCOUVER, British Columbia, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX: LGD; OTCQX: LGDTF) ("Liberty Gold" or the “Company”), is pleased to announce that it has entered into a subscription agreement (the “Subscription”) with Centerra Gold …

Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
HUNTSVILLE, AL, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, announced that Steve Ledger, Chief …

G2 Drilling Significantly Expands New Oko Discovery
Gold mineralisation extended 200 meters down plunge from previous holes 49.0m @ 1.3 g/t Au (AMD54A) 52.0m @ 1.1 g/t Au (AMD56) 46.5m @ 1.0 g/t Au (AMD58) 41.2m @ 1.7 g/t Au (AMD94) Infill drilling confirms near surface, high-grade gold mineralisation 49.5m …